New study tests tezepelumab for chronic sinusitis sufferers

NCT ID NCT07633158

First seen Jun 25, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This study follows 200 adults with severe chronic sinusitis and nasal polyps who are starting tezepelumab as part of their routine care. Researchers will track changes in symptoms and quality of life over up to two years using patient questionnaires. The goal is to see how well the drug works in real-world settings, outside of strict clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tezepelumab
What this could lead to
If successful, this study could show that tezepelumab effectively controls symptoms and reduces the need for steroids or surgery in people with severe nasal polyps.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It is also early-stage real-world evidence, and tezepelumab may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    RECRUITING

    Hamburg, Germany

  • Research Site

    RECRUITING

    Kiel, Germany

  • Research Site

    RECRUITING

    München, Germany

  • Research Site

    RECRUITING

    Neuenhagen, Germany

  • Research Site

    RECRUITING

    Rosenheim, Germany

  • Research Site

    RECRUITING

    Starnberg, Germany

  • Research Site

    RECRUITING

    Tübingen, Germany

  • Research Site

    RECRUITING

    Wiesbaden, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.